Six Awarded CVS Eric Delson Scholarship
WASHINGTON – One medical student. One doctoral researcher in optics and quantum materials. Three students currently enrolled in the sciences, including one wanting to become a physician assistant. Another studying kinesiology and a third studying sociology and public health. Add in one high school student wanting to pursue engineering and you have an impressive and […]
Novo provides update on the denecimig Biologics LicenseApplication (BLA) in the US
The following is a news release from Novo. Read the full release at novonordisk.com Bagsværd, Denmark, 02 October 2026 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has informed Novo that the BLA review of denecimig for the treatment of haemophilia A, with or without inhibitors in adults and children, […]
Working to Save Lives this Suicide Prevention Month
While suicide has dropped from being the tenth leading cause of death in the United States to the eleventh, it remains the second leading cause of death for young people between the ages of 10 and 34. Suicide awareness has become much more prevalent in the United States, thanks in part to work such as […]
Highest Research Award Given to Creators of Hemlibra
When the subcutaneous injectable medication Hemlibra first hit the market in 2017 it was heralded as a game changer for the hemophilia A community. Now in 2026 the three doctors who brought the drug to life are being celebrated for their work with one of the medical research profession’s highest honors. The Lasker Foundation of […]
Editorial: The Preservation of Protection
For more than 50 years a small team at the Centers for Disease Control and Prevention has helped protect Americans living with hemophilia and other inherited blood disorders. Its work rarely makes headlines. But for families who depend on safe treatment, accurate diagnosis, reliable public health data and evidence-based care it can be lifesaving. Today […]
Pfizer Survey Shows Patients Still Want More from Treatment
Hemophilia patients are generally satisfied with their treatment but are more than willing to try something better. That’s the consensus from a recent survey by Pfizer and the Harris Poll. According to the global survey of 1,000 people with hemophilia, 84 % of those asked said they were either somewhat or very satisfied with their […]
Gene Therapy Remains Top of Mind for Hematologists
While the market for hemophilia gene therapy has shrunk in 2026, desire for the treatment remains high. That’s according to a new study from Spherix Global Insights. In a press release issued August 16, the Pennsylvania-based company said their recent survey of European Hematologists showed roughly 90 % of the doctors surveyed expect gene therapies […]
Answering Back to School Questions
When the first school bell rings each year, parents and children with bleeding disorders start to answer a large number of questions. Thankfully, HFA is here with plenty of resources to help you with those answers. Under our ‘Resources & Toolkits’ tab, we have a complete “Back to School” page. There you will find information […]
Don’t Leave Home Without It
If you’re over 40, you will likely remember a series of commercials featuring various semi-famous actors and celebrities telling you about the need to carry the American Express card, and the famous catchphrase “Don’t Leave Home Without It!” If you are of roughly that same generation or older you may have strong opinions on medical […]
Nasal Spray STIMATE Returning To Market This Fall
Ferring Pharmaceuticals has announced their nasal spray STIMATE will return to the market this fall following a six year absence. The nasal spray for Hemophilia A and von Willebrand Type 1 patients was voluntarily recalled in 2020 due to what the pharmaceutical company called a “packaging-related issue, which has now been resolved.” Ferring announced in […]
English 
Español de Puerto Rico